GTCR, Fiorentino enter partnership to form TerSera Therapeutics

GTCR entered into a partnership with Ed Fiorentino to form TerSera Therapeutics LLC, a company that will focus on acquiring specialty pharmaceutical companies and products. Fiorentino is the former chief executive officer of a GTCR-backed company. GTCR's investment in TerSera will be made from GTCR Fund XI, a private equity fund with $3.85 billion in capital commitments.

DealsNorth AmericaUSBriefs